Nephropathy induced by other drugs, medicaments and biological substances
ICD-10 N14.19 is a billable code used to indicate a diagnosis of nephropathy induced by other drugs, medicaments and biological substances.
Nephropathy induced by other drugs, medicaments, and biological substances refers to kidney damage resulting from exposure to various pharmacological agents. This condition can manifest as acute interstitial nephritis, pyelonephritis, or chronic kidney disease, depending on the duration and type of drug exposure. Common culprits include non-steroidal anti-inflammatory drugs (NSAIDs), certain antibiotics, and chemotherapeutic agents. Symptoms may include flank pain, hematuria, and changes in urinary output. Diagnosis typically involves a combination of clinical evaluation, laboratory tests, and imaging studies to assess kidney function and structure. Management often requires discontinuation of the offending agent, supportive care, and in some cases, the use of corticosteroids to reduce inflammation. Close monitoring of renal function is essential to prevent progression to more severe renal impairment.
Detailed history of drug exposure, lab results, and imaging studies.
Patients presenting with acute kidney injury after starting new medications.
Ensure clear documentation of the timeline of drug exposure and renal function tests.
Comprehensive medication lists and assessment of renal function.
Patients with chronic conditions requiring multiple medications presenting with renal impairment.
Documenting the rationale for medication changes and monitoring renal function closely.
Used to assess renal function in patients suspected of drug-induced nephropathy.
Document the reason for the metabolic panel and any abnormal findings.
Nephrologists may require additional renal function tests.
Various drugs, including NSAIDs, certain antibiotics, and chemotherapeutic agents, can lead to nephropathy. It is essential to review the patient's medication history for potential culprits.
